ArticleACS measurement science au2026
Harnessing New Tools for Old Challenges: Optimising Neat Plasma Proteomics with Automation and Gas-Phase Fractionation.
Article in ACS measurement science au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advances in high-throughput mass spectrometry have shifted the bottleneck in plasma proteomics from data acquisition to sample preparation. While enrichment and depletion strategies enable detection of low-abundance proteins, their complexity and cost limit scalability and clinical translation. Targeting midto-high abundance proteins from neat plasma offers a practical, reproducible alternative aligned with clinical workflows. Here, we combine fully automated sample preparation and Evotip loading on the Bravo AssayMAP system with extensive method optimization on the timsTOF HT and gas-phase fractionation deep spectral libraries to advance neat plasma proteomics. Automation reduced hands-on time by 88% and significantly improved robustness. Mixed-mode searching with a 1788-protein library increased identifications by up to 31% at a throughput of 100 samples per day, with less than 15% variation across plates. In a coronary artery disease cohort, we quantified 936 biologically relevant proteins and found 42 dysregulated compared to healthy controls. This streamlined, high-throughput workflow enables deep, reproducible analysis of neat plasma at scale, paving the way for population-level biomarker discovery and clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.